BMRN - BioMarin Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 515.89B
Enterprise Value 316.05B
Trailing P/E N/A
Forward P/E 1328.56
PEG Ratio (5 yr expected) 1-3.62
Price/Sales (ttm)10.46
Price/Book (mrq)5.41
Enterprise Value/Revenue 310.57
Enterprise Value/EBITDA 6-255.33

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -5.90%
Operating Margin (ttm)-10.40%

Management Effectiveness

Return on Assets (ttm)-2.19%
Return on Equity (ttm)-3.12%

Income Statement

Revenue (ttm)1.52B
Revenue Per Share (ttm)8.55
Quarterly Revenue Growth (yoy)7.30%
Gross Profit (ttm)479.62M
EBITDA -62.88M
Net Income Avi to Common (ttm)-89.53M
Diluted EPS (ttm)-0.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)894.85M
Total Cash Per Share (mrq)5
Total Debt (mrq)891.93M
Total Debt/Equity (mrq)30.37
Current Ratio (mrq)3.83
Book Value Per Share (mrq)16.40

Cash Flow Statement

Operating Cash Flow (ttm)7.85M
Levered Free Cash Flow (ttm)-46.21M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.40
52-Week Change 30.35%
S&P500 52-Week Change 35.24%
52 Week High 3106.74
52 Week Low 379.13
50-Day Moving Average 386.73
200-Day Moving Average 391.24

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 31.58M
Shares Outstanding 5179.07M
Float 178.05M
% Held by Insiders 10.45%
% Held by Institutions 1102.88%
Shares Short (Apr 30, 2019) 48.99M
Short Ratio (Apr 30, 2019) 47.52
Short % of Float (Apr 30, 2019) 45.64%
Short % of Shares Outstanding (Apr 30, 2019) 45.02%
Shares Short (prior month Mar 29, 2019) 49.21M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A